新兴的治疗方法来治疗腹痛
Nestor N Jimenez-Vargas1, Nabil Parkar1, Kaede Takami1
1Gastrointestinal Diseases Research Unit, Kingston Health Sciences Centre, Queen's University, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada.
新的疼痛缓解策略针对特定的神经细胞来减少副作用. 研究探讨针对内脏疼痛的组胺和蛋白酶,以及使用pH敏感药物治疗炎症性疼痛.
科学领域:
- 疼痛研究 疼痛研究
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 现有的止痛药,如阿片类药物和NSAIDs,由于非选择性药物作用而引起副作用.
- 药物标往往被广泛表达,导致与疼痛来源无关的非标效应.
- 迫切需要更安全,更有效的疼痛管理疗法.
研究的目的:
- 探索两种机制方法来开发具有减少副作用的向止痛药.
- 专注于内脏感知神经元作为改善治疗特异性的战略.
- 为了确定新的治疗目标和疼痛管理策略.
主要方法:
- 审查机械性疼痛研究的特定疾病,如刺激性肠综合征 (IBS).
- 在内脏疼痛路径中研究神经活性介质,如组胺和蛋白酶.
- 检查针对炎症组织的pH敏感止痛药的使用情况.
主要成果:
- 机理学研究可以在特定条件下识别上调的目标,如IBS.
- 由于它们在内脏疼痛中的作用,胺素和蛋白酶显示出作为治疗点的潜力.
- 对pH敏感的止痛药在酸性炎症环境中有针对性抑制μ-阿片类受体.
结论:
- 研究疾病特异性机制对于开发有针对性的疼痛疗法至关重要.
- 新的生物标志物和治疗策略可以提高治疗特异性并减少副作用.
- 准内脏感知神经元为更安全的疼痛缓解提供了一个有希望的途径.
更多相关视频
05:18Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment
Published on: November 22, 2024
07:20Intraoperative Detection of Subtle Endometriosis: A Novel Paradigm for Detection and Treatment of Pelvic Pain Associated with the Loss of Peritoneal Integrity
Published on: December 21, 2012
相关概念视频
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Analgesia and Pain Management
Irritable Bowel Syndrome III: Medical and Nursing Management
Drugs for Treatment of Constipation-Predominant IBS
